VLA-4 integrin plays a pivotal role in mediating both cell–cell and cell–matrix interactions in CLL-involved tissues by interacting with vascular cell adhesion molecule 1 (VCAM-1) and fibronectin, respectively. This evidence concerns the gene VCAM1 and B-cell chronic lymphocytic leukemia.